Open-Label Extension Study of Setmelanotide

Clinical trial NCT06596135 · COMPLETED

Trial details

NCT number: NCT06596135
Sponsor: Rhythm Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Associated With Defects in Leptin-melanocortin Pathway

Start date: 2024-10-21
Primary completion: 2026-06-24
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.